While the effects of the coronavirus pandemic continue all over the world, vaccination studies continue without slowing down. Although there are some vaccines put into practice in countries, especially side effects and at the point of efficacy rates, there are vaccines that have not yet been able to be confirmed. This prevents these vaccines from being produced in high numbers and applied worldwide.
One of the most discussed vaccines is developed in the USA. Moderna vaccine. Just like the BioNTech vaccine, the reason why Moderna, an mRNA vaccine, was the subject of controversy was that it had a high rate of side effects. Compared with the BioNTech vaccine, Moderna’s side effect rate According to a study by the US Center for Disease Control and Prevention (CDC) 74 percent. In the BioNTech vaccine, this rate was determined as 65.4 percent.
WHO approved emergency use:
In the shadow of these discussions, it is about Moderna in these days, when the priority of the whole world is ‘vaccinating everyone as soon as possible’. A statement was made by WHO. In the written statement made ” Today WHO listed the Moderna COVID-19 vaccine (mRNA 1273) for emergency use ” statements were included. Prior to emergency use approval, the vaccine was reviewed by the Strategic Vaccine Experts Group (SAGE) of WHO and was released in January. For all age groups 18 years and over had been proposed.
Moderna vaccine by the US Food and Drug Administration (CDC) on December 18, 2020 received an emergency use permit. On January 6, 2021, by the European Medicines Agency (EMA) marketing authorization was also granted.